Delivery Order SPE2DB20D3303-SPE2DB24FZ4J7
Award Date
4/11/24
Potential Completion Date
4/12/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $27,796.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has a firm fixed-price pricing type with an ultimate completion date of November 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, valued at $8,335.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. This award is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $42,086.28 and has an ultimate completion date of June 20, 2024. The contract provides the DLA with the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,743.80, is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET 30 count. The contract has a firm fixed price and has a completion date of May 21, 2024. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET medication, with a firm fixed price of $6,840.33 and a completion date of March 8, 2024. The contract does not have any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $11,372.48 and a completion date of November 16, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $10,773.73 delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
The federal contract award, valued at $2,012.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET. The contract is a delivery order with a firm fixed price and has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,055.16 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The contract has an ultimate completion date of February 25, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, valued at $11,059.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2023 and utilizes a Firm Fixed Price pricing type. This award is not associated with a set-aside program....